Viewing Study NCT01227967


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-01-21 @ 10:39 PM
Study NCT ID: NCT01227967
Status: COMPLETED
Last Update Posted: 2019-02-04
First Post: 2010-10-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adaptive Design View
None At Risk View
None H1N1 View
None Synergy View
None TCAD View